Medical devices, healthcare technology and the business of care
510(k) clearance · K261089

Radical 064 Reperfusion Catheter; Radical 076 Reperfusion Catheter; Radical Aspiration Tubing Kit

Maduro Medical, Inc. · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONK261089

What did the FDA decide?

Maduro Medical, Inc. received a substantially equivalent (SESE) decision for K261089 on September 14, 2026, covering the Radical 064 Reperfusion Catheter, Radical 076 Reperfusion Catheter and Radical Aspiration Tubing Kit. The catheters are sterile, single-use intravascular devices for thrombus removal from the neurovasculature with a vacuum pump; the 064 and 076 designations reflect inner diameter sizes of 0.064" and 0.076", with usable lengths of 125–140 cm. The tubing kit is a 112" extension assembly with an on/off flow switch linking the catheter hub to a pump canister.

The submission lists the AXS Vecta Aspiration System (K191768) as predicate, with several reference devices including the Route 92 Medical HiPoint system (K243601). The summary states shared intended use and basic technological characteristics with the predicate. The public record does not include the clinical or bench evidence underlying the decision, and the two source pages give different received dates (August 11, 2026 in the letter, April 1, 2026 in the database entry). Indications described in the summary are those of the cleared labeling, not independently verified clinical findings.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261089
Regulatory pathway
510(k) premarket notification
Product code
NRY
Decision code
SESE
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Thrombus Retriever.

Product code
NRY
FDA device class
2

FDA decision timeline

  1. K261089 received

    Application receipt date recorded by FDA.

  2. K261089 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NRY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Maduro Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Los Gatos, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records